Mounjaro®
Dual-agonist support that helps curb appetite, hunger, and cravings to drive substantial, sustained weight loss.
- ~22.5% average body weight loss
- Significant weight reduction
- Improves blood sugar levels
- Clinically proven weight loss

Does tadalafil cause dependence? This is a common concern for men prescribed this erectile dysfunction medication. Tadalafil, a phosphodiesterase type 5 (PDE5) inhibitor marketed as Cialis in the UK, does not cause physical dependence or addiction. Clinical evidence shows that the body does not develop pharmacological tolerance requiring higher doses over time. However, some men may experience psychological reliance, feeling unable to engage in sexual activity without the medication. Understanding the difference between physical dependence and psychological reliance is essential for safe, confident use of tadalafil under medical supervision.
Summary: Tadalafil does not cause physical dependence or pharmacological tolerance, though some men may develop psychological reliance on the medication.
Tadalafil is a prescription medication primarily used to treat erectile dysfunction (ED) and, in some formulations, benign prostatic hyperplasia (BPH). It belongs to a class of drugs known as phosphodiesterase type 5 (PDE5) inhibitors, which also includes sildenafil and vardenafil. Tadalafil is marketed under brand names such as Cialis in the UK and is available in various doses for different indications: typically 10 mg (adjustable to 5-20 mg) for on-demand treatment of ED, 2.5-5 mg for daily ED treatment, and 5 mg once daily for BPH. It is licensed for adult use only.
The mechanism of action involves the inhibition of the PDE5 enzyme, which is responsible for breaking down cyclic guanosine monophosphate (cGMP) in the smooth muscle cells lining blood vessels. During sexual stimulation, nitric oxide is released in the erectile tissue of the penis, leading to increased cGMP levels. By blocking PDE5, tadalafil allows cGMP to accumulate, promoting relaxation of smooth muscle and increased blood flow to the penis, thereby facilitating an erection. It is important to note that tadalafil does not cause spontaneous erections; sexual arousal is still required for the medication to be effective.
Tadalafil is distinguished from other PDE5 inhibitors by its longer half-life, with effects lasting up to 36 hours. This extended duration of action allows for greater spontaneity in sexual activity. The medication is available in both on-demand formulations (taken before anticipated sexual activity) and daily low-dose options for continuous treatment. Tadalafil is regulated by the Medicines and Healthcare products Regulatory Agency (MHRA) in the UK and should only be used under medical supervision following appropriate assessment of cardiovascular health and potential drug interactions.
A common concern among patients using tadalafil is whether the body develops tolerance to the medication over time, requiring higher doses to achieve the same effect. Available clinical evidence suggests that tadalafil does not typically cause pharmacological tolerance. Studies with follow-up periods of 1-2 years have shown that most patients maintain therapeutic response without needing dose escalation, though longer-term data are limited. The drug's mechanism—enhancing the natural erectile response rather than artificially inducing it—may explain why significant tolerance does not appear to develop.
However, some patients may perceive reduced effectiveness over time. This is often attributable to progression of underlying conditions rather than true tolerance. Erectile dysfunction commonly results from vascular disease, diabetes, or neurological conditions, all of which may worsen with age or inadequate disease management. Additionally, psychological factors such as performance anxiety or relationship stress can influence perceived treatment success. When patients report diminished response, healthcare professionals should reassess cardiovascular risk factors (blood pressure, lipids), glycaemic control in diabetic patients, hormone levels (particularly testosterone) if clinically indicated, and medication adherence.
NICE Clinical Knowledge Summary guidance emphasises the importance of addressing modifiable risk factors alongside pharmacological treatment. Lifestyle interventions—including smoking cessation, weight management, increased physical activity, and alcohol moderation—can significantly improve erectile function and enhance tadalafil's effectiveness. Regular review with a GP or specialist is recommended to monitor treatment response and adjust management strategies accordingly.
It is crucial to understand that physical dependence does not occur with tadalafil. The medication does not alter the body's natural ability to achieve erections; it simply facilitates the process when sexual stimulation occurs. Discontinuing tadalafil does not lead to withdrawal symptoms or permanent impairment of erectile function.
Whilst tadalafil does not cause physical dependence, some men may develop psychological reliance on the medication. This occurs when a patient feels unable to attempt sexual activity without taking the drug, even when the underlying erectile dysfunction may have improved or was initially mild. Psychological reliance is distinct from addiction; there is no compulsive drug-seeking behaviour or physical withdrawal, but rather an anxiety-driven belief that sexual performance is impossible without pharmaceutical assistance.
Several factors contribute to psychological reliance. Men who experience initial success with tadalafil may develop performance anxiety about attempting intercourse without it, fearing failure and embarrassment. This anxiety can become self-fulfilling, as stress and worry themselves impair erectile function. Additionally, younger men with situational or mild ED may begin using tadalafil as a "confidence boost," potentially establishing an unnecessary psychological dependency before exploring underlying causes or alternative interventions. It is important to note that tadalafil is a prescription-only medicine and should not be used recreationally.
When to seek support:
You feel anxious or unable to engage in sexual activity without tadalafil
You are using tadalafil more frequently than prescribed or in higher doses
Relationship difficulties or low self-esteem are affecting your sexual confidence
You experience persistent worry about sexual performance despite treatment success
The NHS recommends that men experiencing psychological barriers to sexual function consider psychosexual counselling or cognitive behavioural therapy (CBT). These evidence-based interventions address performance anxiety, relationship dynamics, and self-esteem issues that may perpetuate reliance on medication. Your GP can provide referrals to appropriate services, which may be available through NHS sexual health clinics, local Improving Access to Psychological Therapies (IAPT) services, or specialist psychosexual therapy services. Combining psychological support with medical treatment often yields better long-term outcomes than medication alone, helping patients regain confidence in their natural sexual function.
Safe and effective use of tadalafil requires adherence to prescribing guidelines established by the MHRA and clinical recommendations from NICE and the NHS. Tadalafil should only be obtained through legitimate prescription channels following medical assessment. The medication is contraindicated in patients taking nitrates (used for angina), nicorandil, or guanylate cyclase stimulators (such as riociguat), as these combinations can cause dangerous drops in blood pressure. Patients with severe cardiovascular disease, recent stroke or myocardial infarction, or uncontrolled hypertension require careful evaluation before tadalafil can be prescribed.
Important interactions include:
CYP3A4 inhibitors (ketoconazole, itraconazole, ritonavir): may increase tadalafil levels, requiring dose adjustment
CYP3A4 inducers (rifampicin, carbamazepine, phenytoin): may reduce tadalafil effectiveness
Alpha-blockers: can cause additive blood pressure lowering; patients should be stable on alpha-blocker therapy before starting tadalafil
Grapefruit juice: may increase tadalafil levels and side effects
Alcohol: may increase the risk of hypotension, dizziness and headache
Dose adjustments are needed in renal impairment, and tadalafil should be avoided in severe hepatic impairment for ED treatment.
Common adverse effects include headache, indigestion, back pain, muscle aches, flushing, and nasal congestion. These are generally mild and transient. However, patients should seek immediate medical attention by calling 999 or attending A&E if they experience:
Sudden vision loss or changes (possible non-arteritic anterior ischaemic optic neuropathy)
Sudden hearing loss or tinnitus
Chest pain during or after sexual activity
Priapism (erection lasting more than four hours), which requires emergency treatment to prevent permanent damage
Severe allergic reactions (rash, difficulty breathing, swelling)
The MHRA advises against purchasing tadalafil from unregulated online sources, as counterfeit medications may contain incorrect doses, harmful substances, or no active ingredient at all. Legitimate UK online pharmacies must be registered with the General Pharmaceutical Council and require valid prescriptions.
Regular review with your GP is essential for ongoing tadalafil use. This allows monitoring of treatment effectiveness, assessment of cardiovascular health, and adjustment of management strategies. Patients should be honest about their medication use to ensure safe prescribing. The NHS emphasises that tadalafil is one component of a comprehensive approach to sexual health, which should include lifestyle modification, management of underlying conditions, and psychological support where appropriate. Suspected side effects should be reported to the MHRA Yellow Card scheme (yellowcard.mhra.gov.uk or via the Yellow Card app). By following medical guidance and maintaining open communication with healthcare providers, patients can use tadalafil safely and effectively without developing problematic patterns of use.
No, tadalafil does not cause physical dependence or withdrawal symptoms. The medication enhances natural erectile response rather than artificially inducing it, and discontinuing use does not permanently impair erectile function.
Most patients do not require dose escalation with long-term tadalafil use. Clinical studies show sustained effectiveness without developing pharmacological tolerance, though underlying health conditions may progress and require reassessment.
Psychological reliance occurs when a patient feels unable to engage in sexual activity without tadalafil due to performance anxiety, despite no physical dependence. Psychosexual counselling or cognitive behavioural therapy can help address this concern.
The health-related content published on this site is based on credible scientific sources and is periodically reviewed to ensure accuracy and relevance. Although we aim to reflect the most current medical knowledge, the material is meant for general education and awareness only.
The information on this site is not a substitute for professional medical advice. For any health concerns, please speak with a qualified medical professional. By using this information, you acknowledge responsibility for any decisions made and understand we are not liable for any consequences that may result.
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur.
Block quote
Ordered list
Unordered list
Bold text
Emphasis
Superscript
Subscript